ORGANIC
LETTERS
2010
Vol. 12, No. 1
184-187
Pd-Catalyzed C-H Functionalizations of
O-Methyl Oximes with Arylboronic Acids
Chang-Liang Sun,† Na Liu,† Bi-Jie Li,† Da-Gang Yu,† Yang Wang,† and
Zhang-Jie Shi*,†,‡
Beijing National Laboratory of Molecular Sciences (BNLMS) and Key Laboratory of
Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of
Chemistry, and State Key Laboratory of Natural and Biomimetic Drugs, Peking
UniVersity, Beijing 100871, China
Received November 9, 2009
ABSTRACT
Useful methods have been developed to construct ortho-arylated aryl aldoximes, aryl ketoximes, and fluorenones via Pd(II)-catalyzed direct
C-H arylation by using arylboronic acids as arylating reagents based on the analysis of the pathways of direct functionalization of aryl
aldoximes.
Direct C-H functionalization is the most straightforward
pathway to construct useful and complicated natural and
synthetic molecules. Recently, many efforts have been
made to pursue this goal.1 Among those methods, func-
tional group oriented ortho C-H activation is a common
strategy to address this problem.2 Actually, the O-methyl
oximyl group has been successfully applied for ortho
acetoxylation and amination.3 Very recently, arylation
followed by further transformation with aryl iodides to
synthesize fluorenones has also been successfully devel-
oped.4
Compared with direct arylation with arylboronic acids
directed by other anchoring groups, the arylation oriented
by CdX (X ) O, N) remains challenging.5 The major issue
(2) (a) Boele, M. D. K.; van Strijdonck, G. P. F.; de Vries, A. H. M.;
Kamer, P. C. J.; de Vries, J. G.; van Leeuwen, P. W. N. M. J. Am. Chem.
Soc. 2002, 124, 1586. (b) Zaitsev, V. G.; Daugulis, O. J. Am. Chem. Soc.
2005, 127, 4156. (c) Kalyani, D.; Deprez, N. R.; Desai, L. V.; Sanford,
M. S. J. Am. Chem. Soc. 2005, 127, 7330. (d) Dick, A. R.; Hull, K. L.;
Sanford, M. S. J. Am. Chem. Soc. 2004, 126, 2300. (e) Giri, R.; Yu, J.-Q.
J. Am. Chem. Soc. 2008, 130, 4082. (f) Tsang, W. C. P.; Zheng, N.;
Buchwald, S. L. J. Am. Chem. Soc. 2005, 127, 14560. (g) Wang, C.; Piel,
I.; Glorius, F. J. Am. Chem. Soc. 2009, 131, 4194. (h) Ackermann, L. Org.
Lett. 2005, 7, 3123. (i) Oi, S.; Fukita, S.; Hirata, N.; Watanuki, N.; Miyano,
S.; Inoue, Y. Org. Lett. 2001, 3, 2579. (j) Campeau, L.-C.; Parisien, M.;
Jean, A.; Fagnou, K. J. Am. Chem. Soc. 2006, 128, 581. (k) Shi, B.; Maugel,
N.; Zhang, Y.; Yu., J. Angew. Chem., Int. Ed. 2008, 47, 4. (l) Houlden,
C. E.; Bailey, C. D.; Ford, J. G.; Gagne, M. R.; Lloyd-Jones, G. C.; Booker-
Milburn., K. I. J. Am. Chem. Soc. 2008, 130, 10066.
† College of Chemistry.
‡ State Key Laboratory of Natural and Biomimetic Drugs.
(1) For recent reviews, see: (a) Godula, K.; Sames, D. Science 2006,
312, 67. (b) Daugulis, O.; Zaitsev, V. G.; Shabashov, D.; Pham, Q. N.;
Lazareva, A. Synlett 2006, 3382. (c) Dick, A. R.; Sanford, M. S. Tetrahedron
2006, 62, 2439. (d) Yu, J.-Q.; Giri, R.; Chen, X. Org. Biomol. Chem. 2006,
4, 4041. (e) Kakiuchi, F.; Chatani, N. AdV. Synth. Catal. 2003, 345, 1077.
(f) Kakiuchi, F.; Murai, S. Acc. Chem. Res. 2002, 35, 826. (g) Ritleng, V.;
Sirlin, C.; Pfeffer, M. Chem. ReV. 2002, 102, 1731. (h) Jia, C.; Kitamura,
T.; Fujiwara, Y. Acc. Chem. Res. 2001, 34, 633. (i) Dyker, G. Angew. Chem.,
Int. Ed. 1999, 38, 1699. (j) Li, B.-J.; Yang, S.-D.; Shi., Z.-J. Synlett 2008,
7, 949.
(3) (a) Desai, L. V.; Hull, K. L.; Sanford, M. S. J. Am. Chem. Soc.
2004, 126, 9542. (b) Thu, H.; Yu, W.; Che, C. J. Am. Chem. Soc. 2006,
128, 9048.
(4) (a) Thirunavukkarasu, V. S.; Parthasarathy, K.; Cheng, C. Angew.
Chem., Int. Ed. 2008, 47, 9462. (b) Shabashov, D.; Maldonado, J. R. M.;
Daugulis, O. J. Org. Chem. 2008, 73, 7818.
(5) Gu¨rbu¨z, N.; o¨zdemir, I.; C¸ etinkaya, B. Tetrahedron Lett. 2005, 46,
2273.
10.1021/ol902552v 2010 American Chemical Society
Published on Web 12/02/2009